Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group:Routin treatment(Omeprazole20(Produced in Abidi Pharmaceutical Company) +Amoxicillin1+ Clarithromycin500(Produced in Toliddaru Pharmaceutical Company) BID)+ Herbal
Sponsors
Barij Research Center of Medicinal Herbs
Vice chancellor for research of Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Confirmation of Helicobacter Pylori infection by gastroenterologist with the help of a sample of pathology taken in the endoscopy or a positive result of anti-Helicobacter pylori antibodies in the serum sample of patients Patients with functional dyspepsia or gastroduodenal ulcer have indications of eradication of Helicobacter pylori infection
Exclusion criteria
Exclusion criteria: A person with advanced chronic disease Any allergy to the drugs used in the study Pregnancy or breastfeeding Substance abuse or alcohol use Having a history of treatment to eradicate Helicobacter pylori infection Taking antibiotics or bismuth 4 weeks before entering the study Constipation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical signs. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Eradication rate of helicobacter pylori. Timepoint: after 1 months from the end of treatment. Method of measurement: stool antigen for helicobacter pylori. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactM.Taghizadeh
Kashan University of Medical Sciences
Outcome results
None listed